Article Details

Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma

Retrieved on: 2024-11-04 19:36:32

Tags for this article:

Click the tags to see associated articles and topics

Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma. View article details on hiswai:

Excerpt

The FDA has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to ALLO-316, an investigational AlloCAR T product for adult patients ...

Article found on: www.urologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up